Thus, the unique C-fiber-related hypoalgesia as well as known hyperalgesia through LPA1 and LPA3-mediated mechanisms seems to be common in type I and type II diabetic models, which are caused by the destruction of pancreatic insulin-containing β-cells and closely related to metabolic disease, respectively. Here, LPAR3 is linked to metabolic disease.